Nurse Practitioner · Mason, OH
NPI
1649419912
Since 2009
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
7450 S Mason Montgomery Rd Unit 200
Mason, OH, 45040
Phone (513) 585-2410
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
390 services
Medicare patients, 2024
240
Average age 72
Drug cost, 2024
$1.1M
5,169 prescriptions
Company payments, 2025
$796
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julie A Henry was code 99214 (office e&m - established), 336 times for 218 patients. In total Julie A Henry billed 390 services in 10 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 336 | 218 | $74.85 | $25K |
| 99204 Office E&M - New | Office | 18 | 18 | $96.03 | $1,728 |
| 93242 Electrocardiogram | Office | 12 | 12 | $8.55 | $103 |
By year: 2022 $22K for 271 services; 2023 $29K for 402 services; 2024 $28K for 390 services.
Medicare prescription drug claims, 2024
In 2024, the drug Julie A Henry prescribed most often to Medicare patients was Rosuvastatin Calcium, with 562 prescriptions and refills. In total Julie A Henry wrote 5,169 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 562 | 1,539 | 206 | $6,224 |
| Amlodipine Besylate Generic | 496 | 1,173 | 171 | $1,961 |
| Metoprolol Succinate Generic | 398 | 992 | 127 | $3,948 |
| Atorvastatin Calcium Generic | 257 | 694 | 97 | $1,796 |
| Losartan Potassium Generic | 249 | 688 | 98 | $2,137 |
| Ranolazine Er Ranolazine | 241 | 458 | 63 | $23K |
| Torsemide Generic | 240 | 453 | 82 | $3,198 |
| Entresto Sacubitril/Valsartan | 239 | 348 | 59 | $211K |
| Nitroglycerin Patch Nitroglycerin | 213 | 424 | 58 | $11K |
| Repatha Sureclick Evolocumab | 179 | 248 | 37 | $140K |
| Valsartan Generic | 147 | 369 | 56 | $2,455 |
| Nitroglycerin Generic | 144 | 147 | 84 | $1,507 |
| Ezetimibe Generic | 134 | 316 | 52 | $2,668 |
| Jardiance Empagliflozin | 106 | 229 | 42 | $132K |
| Carvedilol Generic | 102 | 248 | 39 | $664 |
Brand drugs: 842 claims; generic drugs: 4,327 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julie A Henry $796 ($796 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbott Laboratories with $299.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 3 | $299 |
| Gentuity, LLC | 2 | $220 |
| Philips North America LLC PHG | 1 | $119 |
| Medline Industries LP | 1 | $41.48 |
| Baxter Healthcare BAX | 1 | $33.12 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $30.53 |
| Axsome Therapeutics, Inc. AXSM | 1 | $20.87 |
| Lilly USA, LLC LLY | 1 | $17 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $14.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.